Structure and biological interactions of heparin and heparan sulfate.

[1]  G. Torri,et al.  Conformation of heparin pentasaccharide bound to antithrombin III. , 2001, The Biochemical journal.

[2]  G. Torri,et al.  Combined Quantitative 1H and 13C Nuclear Magnetic Resonance Spectroscopy for Characterization of Heparin Preparations , 2001, Seminars in thrombosis and hemostasis.

[3]  G. Torri,et al.  Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide. , 2001, Seminars in thrombosis and hemostasis.

[4]  M. Redondo-Horcajo,et al.  The Activation of Fibroblast Growth Factors by Heparin: Synthesis, Structure, and Biological Activity of Heparin‐Like Oligosaccharides , 2001, Chembiochem : a European journal of chemical biology.

[5]  G. Giménez-Gallego,et al.  Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.

[6]  L. Lay,et al.  A Rational Approach to Heparin‐Related Fragments − Synthesis of Differently Sulfated Tetrasaccharides as Potential Ligands for Fibroblast Growth Factors , 2001 .

[7]  M. Salmivirta,et al.  Binding of Heparin/Heparan Sulfate to Fibroblast Growth Factor Receptor 4* , 2001, The Journal of Biological Chemistry.

[8]  K. Kimata,et al.  Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. , 2001, Biochemistry.

[9]  J. Herbert,et al.  SR123781A, a Synthetic Heparin Mimetic , 2001, Thrombosis and Haemostasis.

[10]  J. Esko,et al.  Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. , 2001, The Journal of biological chemistry.

[11]  Z. Shriver,et al.  Direct isolation and sequencing of specific protein-binding glycosaminoglycans , 2001, Nature Medicine.

[12]  K. Kleesiek,et al.  Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. , 2000, Journal of molecular biology.

[13]  J. Angulo,et al.  Interaction of heparin with Ca2+: A model study with a synthetic heparin‐like hexasaccharide , 2000 .

[14]  R. Sasisekharan,et al.  Heparin and heparan sulfate: biosynthesis, structure and function. , 2000, Current opinion in chemical biology.

[15]  M. Forster,et al.  Conformation and dynamics of heparin and heparan sulfate. , 2000, Glycobiology.

[16]  E. Yates,et al.  Effect of substitution pattern on 1H, 13C NMR chemical shifts and 1J(CH) coupling constants in heparin derivatives. , 2000, Carbohydrate research.

[17]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[18]  H. Kitagawa,et al.  The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis , 2000, EMBO reports.

[19]  M. Kyogashima,et al.  Preparation of Completely 6-O-Desulfated Heparin and Its Ability to Enhance Activity of Basic Fibroblast Growth Factor* , 2000, The Journal of Biological Chemistry.

[20]  M. Salmivirta,et al.  Selectively Desulfated Heparin Inhibits Fibroblast Growth Factor-induced Mitogenicity and Angiogenesis* , 2000, The Journal of Biological Chemistry.

[21]  U. Desai,et al.  Role of Arginine 129 in Heparin Binding and Activation of Antithrombin* , 2000, The Journal of Biological Chemistry.

[22]  N. Perrimon,et al.  Specificities of heparan sulphate proteoglycans in developmental processes , 2000, Nature.

[23]  L. Kjellén,et al.  Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns. , 2000, Biochemistry.

[24]  Expression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphation. , 2000, The Biochemical journal.

[25]  M. Humphries,et al.  Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin* , 2000, The Journal of Biological Chemistry.

[26]  G. Hu,et al.  Targeted disruption of NDST‐1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice , 2000, FEBS letters.

[27]  K. Yoshida,et al.  The Occurrence of Three Isoforms of Heparan Sulfate 6-O-Sulfotransferase Having Different Specificities for Hexuronic Acid Adjacent to the TargetedN-Sulfoglucosamine* , 2000, The Journal of Biological Chemistry.

[28]  S. Selleck,et al.  The Elusive Functions of Proteoglycans , 2000, The Journal of cell biology.

[29]  N. Krishna,et al.  Molecular structure of the carbohydrate-protein linkage region fragments from connective-tissue proteoglycans. , 2000, Advances in carbohydrate chemistry and biochemistry.

[30]  K. Yoshida,et al.  Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase-3A SulfatesN-Unsubstituted Glucosamine Residues* , 1999, The Journal of Biological Chemistry.

[31]  K. Nordling,et al.  A novel strategy to generate biologically active neo-glycosaminoglycan conjugates. , 1999, Glycobiology.

[32]  R. Timpl,et al.  Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin , 1999, The EMBO journal.

[33]  G. Giménez-Gallego,et al.  Common Binding Sites for β-Amyloid Fibrils and Fibroblast Growth Factor-2 in Heparan Sulfate from Human Cerebral Cortex* , 1999, The Journal of Biological Chemistry.

[34]  Z. Shriver,et al.  Sequencing complex polysaccharides. , 1999, Science.

[35]  R. Eisenberg,et al.  A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry , 1999, Cell.

[36]  J. Herbert,et al.  Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2. , 1999, Bioorganic & medicinal chemistry.

[37]  H. Kitagawa,et al.  Purification and characterization of fetal bovine serum beta-N-acetyl-D-galactosaminyltransferase and beta-D-glucuronyltransferase involved in chondroitin sulfate biosynthesis. , 1999, European journal of biochemistry.

[38]  M. Nakajima,et al.  Human Heparanase , 1999, The Journal of Biological Chemistry.

[39]  L. Hellman,et al.  Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme , 1999, Nature.

[40]  J. Herbert,et al.  A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers. , 1999, Bioorganic & medicinal chemistry.

[41]  X. Wu,et al.  Requirement for Anticoagulant Heparan Sulfate in the Fibroblast Growth Factor Receptor Complex* , 1999, The Journal of Biological Chemistry.

[42]  R. Pettersson,et al.  Characterization of fibroblast growth factor 1 binding heparan sulfate domain. , 1999, Glycobiology.

[43]  O. Pappo,et al.  Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis , 1999, Nature Medicine.

[44]  R. Baker,et al.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis , 1999, Nature Medicine.

[45]  M. Lyon,et al.  Highly Sensitive Sequencing of the Sulfated Domains of Heparan Sulfate* , 1999, The Journal of Biological Chemistry.

[46]  H. Kitagawa,et al.  Involvement of the core protein in the first beta-N-acetylgalactosamine transfer to the glycosaminoglycan-protein linkage-region tetrasaccharide and in the subsequent polymerization: the critical determining step for chondroitin sulphate biosynthesis. , 1999, The Biochemical journal.

[47]  H. Kitagawa,et al.  The Tumor Suppressor EXT-like Gene EXTL2 Encodes an α1, 4-N-Acetylhexosaminyltransferase That TransfersN-Acetylgalactosamine and N-Acetylglucosamine to the Common Glycosaminoglycan-Protein Linkage Region , 1999, The Journal of Biological Chemistry.

[48]  J. Gallagher,et al.  Monomer Complexes of Basic Fibroblast Growth Factor and Heparan Sulfate Oligosaccharides Are the Minimal Functional Unit for Cell Activation* , 1999, The Journal of Biological Chemistry.

[49]  M. Guerrini,et al.  Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts. , 1999, European journal of biochemistry.

[50]  A Kinoshita,et al.  Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides. , 1999, Analytical biochemistry.

[51]  M. Salmivirta,et al.  Sequence analysis of heparan sulphate and heparin oligosaccharides. , 1999, The Biochemical journal.

[52]  J. Herbert,et al.  Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'. , 1999, Carbohydrate research.

[53]  J. Herbert,et al.  Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition. , 1999, Carbohydrate research.

[54]  J. Herbert,et al.  Synthesis of thrombin-inhibiting heparin mimetics without side effects , 1999, Nature.

[55]  J. Turnbull,et al.  A strategy for rapid sequencing of heparan sulfate and heparin saccharides. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Timpl,et al.  Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α‐dystroglycan and several extracellular matrix proteins , 1999 .

[57]  A. Ylinen,et al.  Reg1ulatory Role and Molecular Interactions of a Cell-Surface Heparan Sulfate Proteoglycan (N-syndecan) in Hippocampal Long-Term Potentiation , 1999, The Journal of Neuroscience.

[58]  J. Esko,et al.  Molecular Cloning and Expression of a Third Member of the Heparan Sulfate/Heparin GlcNAcN-Deacetylase/ N-Sulfotransferase Family* , 1999, The Journal of Biological Chemistry.

[59]  K. Yoshida,et al.  Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin. , 1999, Biochemistry.

[60]  R. Beddington,et al.  Cell surface proteoglycans in signalling and development , 1999 .

[61]  M. Götte,et al.  Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.

[62]  K. Haustein.  Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon , 1999, Seminars in thrombosis and hemostasis.

[63]  K. Holme,et al.  Heparin in inflammation: potential therapeutic applications beyond anticoagulation. , 1999, Advances in pharmacology.

[64]  R. Linhardt,et al.  Chemical sulfonation and anticoagulant activity of acharan sulfate. , 1998, Thrombosis research.

[65]  K. Biemann,et al.  Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. McCormick,et al.  The Putative Tumor Suppressors EXT1 and EXT2 Are Glycosyltransferases Required for the Biosynthesis of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[67]  D. Rees,et al.  Diversity does make a difference: fibroblast growth factor-heparin interactions. , 1998, Current opinion in structural biology.

[68]  L. Kjellén,et al.  Regulated Diversity of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[69]  J. Turnbull,et al.  Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity* , 1998, The Journal of Biological Chemistry.

[70]  D. H. Kim,et al.  Determination of the structure of oligosaccharides prepared from acharan sulfate. , 1998, Glycobiology.

[71]  L. Toma,et al.  The Putative Heparin-specific N-AcetylglucosaminylN-Deacetylase/N-Sulfotransferase Also Occurs in Non-heparin-producing Cells* , 1998, The Journal of Biological Chemistry.

[72]  U. Desai,et al.  Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. , 1998, Biochemistry.

[73]  I. Vlodavsky,et al.  Substrate Specificity of Heparanases from Human Hepatoma and Platelets* , 1998, The Journal of Biological Chemistry.

[74]  M. Watanabe,et al.  Conversion of N-sulfated glucosamine to N-sulfated mannosamine in an unsaturated heparin disaccharide by non-enzymatic, base-catalyzed C-2 epimerization during enzymatic oligosaccharide preparation. , 1998, Carbohydrate research.

[75]  D. Ornitz,et al.  FGF signaling in skeletal development. , 1998, Frontiers in bioscience : a journal and virtual library.

[76]  G. Waksman,et al.  New insights into heparin-induced FGF oligomerization , 1998, Nature Structural Biology.

[77]  Wayne A. Hendrickson,et al.  Structure of a heparin-linked biologically active dimer of fibroblast growth factor , 1998, Nature.

[78]  D. Spillmann,et al.  Defining the Interleukin-8-binding Domain of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[79]  J. Karlinsky,et al.  cDNA cloning, genomic organization and chromosomal localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase-2. , 1998, The Biochemical journal.

[80]  D. Martindale,et al.  The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate , 1998, Nature Genetics.

[81]  M. Salmivirta,et al.  Age-dependent Modulation of Heparan Sulfate Structure and Function* , 1998, The Journal of Biological Chemistry.

[82]  R. Hoet,et al.  Generation and Application of Type-specific Anti-Heparan Sulfate Antibodies Using Phage Display Technology , 1998, The Journal of Biological Chemistry.

[83]  L. Kjellén,et al.  Identification and Expression in Mouse of Two Heparan Sulfate Glucosaminyl N-Deacetylase/N-Sulfotransferase Genes* , 1998, The Journal of Biological Chemistry.

[84]  M. Porcionatto,et al.  Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. , 1998, Cellular and molecular biology.

[85]  A. M. Lawson,et al.  Characterization of heparin oligosaccharide mixtures as ammonium salts using electrospray mass spectrometry. , 1998, Analytical chemistry.

[86]  K. Biemann,et al.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[87]  C. Parish,et al.  Human platelet heparanase: purification, characterization and catalytic activity. , 1998, The Biochemical journal.

[88]  S. Yamada,et al.  Structure of Oligosaccharides Isolated from Heparan Sulfate/Heparin and Substrate Specificities of the Degrading Enzymes of Bacterial Origin , 1998 .

[89]  R. Linhardt,et al.  Structural Analysis of Heparan Sulfate and Heparan Sulfate Oligosaccharides. , 1998 .

[90]  Robert Langer,et al.  Pyranose Ring Flexibility. Mapping of Physical Data for Iduronate in Continuous Conformational Space , 1998 .

[91]  J. Turnbull,et al.  Structural Modification of Fibroblast Growth Factor-binding Heparan Sulfate at a Determinative Stage of Neural Development* , 1998, The Journal of Biological Chemistry.

[92]  J. Weiler,et al.  Glycosaminoglycan‐protein interactions: definition of consensus sites in glycosaminoglycan binding proteins , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[93]  K. Yoshida,et al.  A Major Common Trisulfated Hexasaccharide Core Sequence, Hexuronic Acid(2-Sulfate)-Glucosamine(N-Sulfate)-Iduronic Acid-N-Acetylglucosamine-Glucuronic Acid-Glucosamine(N-Sulfate), Isolated from the Low Sulfated Irregular Region of Porcine Intestinal Heparin* , 1998, The Journal of Biological Chemistry.

[94]  Y. Knirel,et al.  Structural features of sulfated chitosans , 1997 .

[95]  M. Jalkanen,et al.  Biosynthesis of Heparin/Heparan Sulfate , 1997, The Journal of Biological Chemistry.

[96]  U. Lindahl,et al.  Amyloid-specific Heparan Sulfate from Human Liver and Spleen* , 1997, The Journal of Biological Chemistry.

[97]  J. Weiler,et al.  Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. , 1997, Archives of biochemistry and biophysics.

[98]  D. Spillmann,et al.  Structural Requirement of Heparan Sulfate for Interaction with Herpes Simplex Virus Type 1 Virions and Isolated Glycoprotein C* , 1997, The Journal of Biological Chemistry.

[99]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[100]  R. Rosenberg.  Biochemistry and pharmacology of low molecular weight heparin. , 1997, Seminars in hematology.

[101]  J. Esko,et al.  Turnover of Heparan Sulfate Depends on 2-O-Sulfation of Uronic Acids* , 1997, The Journal of Biological Chemistry.

[102]  J. Kovensky,et al.  Chemical modification of glycosaminoglycans selective 2-sulfation of d-glucuronic acid units in heparan sulfate , 1997 .

[103]  S. Stringer,et al.  Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate* , 1997, The Journal of Biological Chemistry.

[104]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[105]  E. Yates,et al.  Modifications under basic conditions of the minor sequences of heparin containing 2,3 or 2,3,6 sulfatedd-glucosamine residues , 1997 .

[106]  S. Pérez,et al.  Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments. , 1997, Bioorganic & medicinal chemistry.

[107]  T. A. Fritz,et al.  Partial purification and substrate specificity of heparan sulfate alpha-N-acetylglucosaminyltransferase I: synthesis, NMR spectroscopic characterization and in vitro assays of two aryl tetrasaccharides. , 1997, Glycobiology.

[108]  L. Paka,et al.  Endothelial Cell Heparanase Modulation of Lipoprotein Lipase Activity , 1997, The Journal of Biological Chemistry.

[109]  R. Linhardt,et al.  Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. , 1997, Biochemical and biophysical research communications.

[110]  Z. Witczak,et al.  Carbohydrates in Drug Design , 1997 .

[111]  K. Kimata,et al.  Molecular Cloning and Expression of Chinese Hamster Ovary Cell Heparan-sulfate 2-Sulfotransferase* , 1997, The Journal of Biological Chemistry.

[112]  G. Torri,et al.  Motional properties of E. coli polysaccharide K5 in aqueous solution analyzed by NMR relaxation measurements. , 1997, Carbohydrate research.

[113]  D. Letourneur,et al.  Synthesis and characterization of highly sensitive heparin probes for detection of heparin-binding proteins. , 1997, Analytical biochemistry.

[114]  J. Thompson,et al.  Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides. , 1997, European Journal of Cell Biology.

[115]  R. Powers,et al.  Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. , 1997, Biochemistry.

[116]  R. Wait,et al.  Molecular Weight Measurements of Low Molecular Weight Heparins by Gel Permeation Chromatography , 1997, Thrombosis and Haemostasis.

[117]  E. Yates,et al.  Evidence for a heparin derivative containing an N-sulfated aziridine ring that retains high anti-factor Xa activity , 1997 .

[118]  B. Mannervik,et al.  Molecular cloning and characterization of the thiolesterase glyoxalase II from Arabidopsis thaliana. , 1997, The Biochemical journal.

[119]  H. Yoshida,et al.  Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. , 1997, The Biochemical journal.

[120]  D. Spillmann,et al.  Characterization of Heparin and Heparan Sulfate Domains Binding to the Long Splice Variant of Platelet-derived Growth Factor A Chain* , 1997, The Journal of Biological Chemistry.

[121]  R. Linhardt,et al.  Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides. , 1997, Glycobiology.

[122]  U. Lindahl.  Heparan sulfate - a polyanion with multiple messages , 1997 .

[123]  R. Linhardt,et al.  NMR solution conformation of heparin-derived hexasaccharide. , 1996, The Biochemical journal.

[124]  J. Smith,et al.  Fibroblast growth factors and their receptors. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[125]  S. Olson,et al.  Antithrombin. A bloody important serpin. , 1997, Advances in experimental medicine and biology.

[126]  Job Harenberg,et al.  Nonanticoagulant Actions of Glycosaminoglycans , 2011, Springer US.

[127]  R. Linhardt,et al.  Enzymatic Preparation of Heparin Oligosaccharides Containing Antithrombin III Binding Sites* , 1996, The Journal of Biological Chemistry.

[128]  E. Yates,et al.  1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. , 1996, Carbohydrate research.

[129]  N. Rahimi,et al.  Phosphatidylinositol 3-Kinase Activity Is Required for Hepatocyte Growth Factor-induced Mitogenic Signals in Epithelial Cells* , 1996, The Journal of Biological Chemistry.

[130]  M. Charng,et al.  FKBP-12 Recognition Is Dispensable For Signal Generation by Type I Transforming Growth Factor-β Receptors* , 1996, The Journal of Biological Chemistry.

[131]  J. Vliegenthart,et al.  Polydispersity in sulfation profile of oligosaccharide alditols isolated from the protein-linkage region and the repeating disaccharide region of chondroitin 4-sulfate of bovine nasal septal cartilage. , 1996, European journal of biochemistry.

[132]  M. Salmivirta,et al.  Heparan sulfate : a piece of information , 2004 .

[133]  H. Su,et al.  Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum , 1996, Applied and environmental microbiology.

[134]  J. Esko,et al.  An Animal Cell Mutant Defective in Heparan Sulfate Hexuronic Acid 2-O-Sulfation* , 1996, The Journal of Biological Chemistry.

[135]  U. Lindahl,et al.  Domain Structure of Heparan Sulfates from Bovine Organs* , 1996, The Journal of Biological Chemistry.

[136]  H. Engelberg.  Actions of heparin in the atherosclerotic process. , 1996, Pharmacological reviews.

[137]  R. Linhardt,et al.  A New Glycosaminoglycan from the Giant African Snail Achatina fulica(*) , 1996, The Journal of Biological Chemistry.

[138]  J. Hopwood,et al.  Structures of Five Sulfated Hexasaccharides Prepared from Porcine Intestinal Heparin Using Bacterial Heparinase , 1996, The Journal of Biological Chemistry.

[139]  R. Langer,et al.  Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum. , 1996, The Biochemical journal.

[140]  R. Linhardt,et al.  C-2 Epimerization of N-Acetylglucosamine in an Oligosaccharide Derived From Heparan Sulfate , 1996 .

[141]  K. Holme,et al.  Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. , 1996, Glycobiology.

[142]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[143]  H. Rauvala,et al.  Neurite Outgrowth in Brain Neurons Induced by Heparin-binding Growth-associated Molecule (HB-GAM) Depends on the Specific Interaction of HB-GAM with Heparan Sulfate at the Cell Surface (*) , 1996, The Journal of Biological Chemistry.

[144]  J. van den Born,et al.  Presence of N-Unsubstituted Glucosamine Units in Native Heparan Sulfate Revealed by a Monoclonal Antibody (*) , 1995, The Journal of Biological Chemistry.

[145]  U. R. Desai,et al.  Strategy for the sequence analysis of heparin. , 1995, Glycobiology.

[146]  G. Torri,et al.  Conformational analysis of heparin epoxide in aqueous solution. An NMR relaxation study. , 1995, Carbohydrate research.

[147]  I. Lax,et al.  Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? , 1995, Cell.

[148]  E. Hounsell.  1H NMR in the Structural and Conformational Analysis of Oligosaccharides and Glycoconjugates , 1995 .

[149]  R. Linhardt,et al.  Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin. , 1995, Carbohydrate research.

[150]  J. Turnbull,et al.  Molecular organization of the interferon gamma-binding domain in heparan sulphate. , 1995, The Biochemical journal.

[151]  P. Grootenhuis,et al.  Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity , 1995, Nature Structural Biology.

[152]  N. Razi,et al.  Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide. , 1995, The Biochemical journal.

[153]  J. Fareed,et al.  Molecular profiling and weight determination of heparins and depolymerized heparins. , 1995, Journal of pharmaceutical sciences.

[154]  A. Varki,et al.  Endothelial Heparan Sulfate Proteoglycans That Bind to L-Selectin Have Glucosamine Residues with Unsubstituted Amino Groups (*) , 1995, The Journal of Biological Chemistry.

[155]  G. Waksman,et al.  FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. , 1995, Science.

[156]  K. Yoshida,et al.  Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin. , 1995, The Journal of biological chemistry.

[157]  G. Olivecrona,et al.  Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments. , 1995, The Biochemical journal.

[158]  T. Lohman,et al.  Thermodynamics of charged oligopeptide-heparin interactions. , 1995, Biochemistry.

[159]  B. Coxon,et al.  Physicochemical Characterization of Low Molecular Weight Heparin , 1995 .

[160]  L. Eriksson,et al.  Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease. , 1995, The Biochemical journal.

[161]  R. Linhardt,et al.  Preparation and structural characterization of large heparin-derived oligosaccharides. , 1995, Glycobiology.

[162]  K. Yamada,et al.  Alternatively Spliced Juxtamembrane Domain of a Tyrosine Kinase Receptor Is a Multifunctional Regulatory Site , 1995, The Journal of Biological Chemistry.

[163]  S. Hansen,et al.  Isolation and characterization of hexasaccharides derived from heparin. Analysis by HPLC and elucidation of structure by 1H NMR. , 1995, Carbohydrate research.

[164]  J. Gallagher.  Heparan Sulphate and Protein Recognition , 1995 .

[165]  R. Langer,et al.  Enzymatic degradation of glycosaminoglycans. , 1995, Critical reviews in biochemistry and molecular biology.

[166]  M. Ishihara.  Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. , 1994, Glycobiology.

[167]  N. Razi,et al.  Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5. , 1994 .

[168]  I. Goldberg,et al.  Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. , 1994, The Journal of biological chemistry.

[169]  J. Lear,et al.  Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. , 1994, Biochemistry.

[170]  P. Dell’Era,et al.  Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. , 1994, Biochemical and biophysical research communications.

[171]  A. Al-Hakim,et al.  Separation of glycosaminoglycan-derived oligosaccharides by capillary electrophoresis using reverse polarity. , 1994, Analytical biochemistry.

[172]  K. Khoo,et al.  Structural studies on the oligosaccharides isolated from bovine kidney heparan sulphate and characterization of bacterial heparitinases used as substrates. , 1994, Glycobiology.

[173]  K. Holme,et al.  Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor. , 1994, Glycobiology.

[174]  J. Gallagher.  Dermatan sulphate proteoglycans: edited by J. E. Scott, Portland Press, 1993. £75.00 (374 pages) ISBN 1 85578 0518 , 1994 .

[175]  D. Spillmann,et al.  More to "heparin" than anticoagulation. , 1994, Thrombosis research.

[176]  M. Lyon,et al.  Liver heparan sulfate structure. A novel molecular design. , 1994, The Journal of biological chemistry.

[177]  M. Pantoliano,et al.  Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.

[178]  R. Iozzo.  Perlecan: a gem of a proteoglycan. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[179]  P. Stein,et al.  Biological implications of a 3 A structure of dimeric antithrombin. , 1994, Structure.

[180]  A. Drake,et al.  The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study. , 1994, Carbohydrate research.

[181]  U. R. Desai,et al.  Molecular weight of low molecular weight heparins by 13C nuclear magnetic resonance spectroscopy. , 1994, Carbohydrate research.

[182]  G. Torri,et al.  Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling. , 1994, Analytical biochemistry.

[183]  K. Khoo,et al.  Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates. , 1994, Glycobiology.

[184]  W. Hol,et al.  The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactions , 1994, Nature Structural Biology.

[185]  M. Petitou,et al.  The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics , 1993 .

[186]  U. Lindahl,et al.  Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis. , 1993, Glycobiology.

[187]  B. Olwin,et al.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.

[188]  U. R. Desai,et al.  Substrate specificity of the heparin lyases from Flavobacterium heparinum. , 1993, Archives of biochemistry and biophysics.

[189]  U. Lindahl,et al.  Biosynthesis of heparin/heparan sulfate. Identification of a 70-kDa protein catalyzing both the D-glucuronosyl- and the N-acetyl-D-glucosaminyltransferase reactions. , 1993, The Journal of biological chemistry.

[190]  H. Margalit,et al.  Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. , 1993, The Journal of biological chemistry.

[191]  N. Volpi.  "Fast moving" and "slow moving" heparins, dermatan sulfate, and chondroitin sulfate: qualitative and quantitative analysis by agarose-gel electrophoresis. , 1993, Carbohydrate research.

[192]  H. Nader,et al.  Structure of heparan sulfate from the fresh water mollusc Anomantidae sp: sequencing of its disaccharide units. , 1993, The International journal of biochemistry.

[193]  C. Baiocchi,et al.  Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion. Application of liquid chromatography-mass spectrometry with an atmospheric pressure interface. , 1993, Journal of chromatography.

[194]  M. Forster,et al.  N.m.r. and molecular-modelling studies of the solution conformation of heparin. , 1993, The Biochemical journal.

[195]  G. David.  Integral membrane heparan sulfate proteoglycans , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[196]  J. Hirsh.  Low molecular weight heparin , 2007 .

[197]  K. Khoo,et al.  FABMS/derivatisation strategies for the analysis of heparin-derived oligosaccharides. , 1993, Carbohydrate research.

[198]  H. Nader,et al.  Conformation of the Unsaturated Uronic Acid Residues of Glycosamtnoglycan Disaccharides , 1993 .

[199]  G. Torri,et al.  Alkali-Induced Optical Rotation Changes in Heparins and Heparan Sulfates, and Their Relation to Iduronic Acid-Containing Sequences , 1993 .

[200]  R. Linhardt,et al.  Nature of the interaction of heparin with acidic fibroblast growth factor. , 1993, Biochemistry.

[201]  V. Nurcombe,et al.  Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. , 1993, Science.

[202]  M. Kiefer,et al.  Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[203]  K. Khoo,et al.  Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin. , 1993, The Journal of biological chemistry.

[204]  U. Lindahl,et al.  Glycosaminoglycans and the regulation of blood coagulation. , 1993, The Biochemical journal.

[205]  John E. Scott.  Dermatan sulphate proteoglycans : chemistry, biology, chemical pathology , 1993 .

[206]  J. Turnbull.  Oligosaccharide mapping and sequence analysis of glycosaminoglycans. , 1993, Methods in molecular biology.

[207]  J. Mulliken,et al.  Isolation and characterization of human heparin. , 1992, Biochemistry.

[208]  R. Linhardt,et al.  Negative Ion Fast-Atom Bombardment Tandem Mass Spectrometry To Determine Sulfate and Linkage Position in Glycosaminoglycan-Derived Disaccharides , 1992, Journal of the American Society for Mass Spectrometry.

[209]  K. Yoshida,et al.  One- and two-dimensional 1H-NMR characterization of two series of sulfated disaccharides prepared from chondroitin sulfate and heparan sulfate/heparin by bacterial eliminase digestion. , 1992, Journal of biochemistry.

[210]  B. Faller,et al.  Heparin-induced conformational change and activation of mucus proteinase inhibitor. , 1992, Biochemistry.

[211]  J. Weiler,et al.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. , 1992, Journal of pharmaceutical sciences.

[212]  S. Olson,et al.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. , 1992, The Journal of biological chemistry.

[213]  J. Turnbull,et al.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.

[214]  W. Guo,et al.  The interaction of biological molecules with heparin and related glycosaminoglycans. 1. Identification of a specific heparin binding site for histamine , 1992 .

[215]  J. Hopwood,et al.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates. , 1992, The Biochemical journal.

[216]  J. Esko,et al.  Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans , 1992, The Journal of cell biology.

[217]  I. Vlodavsky,et al.  Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix. , 1992, Biochemistry.

[218]  P. Gettins,et al.  1H-N.m.r. spectral assignments for two series of heparin-derived oligosaccharides. , 1992, Carbohydrate research.

[219]  C. Baiocchi,et al.  High-performance liquid chromatographic-mass spectrometric analysis of oligosaccharides from enzymatic digestion of glycosaminoglycans. Application to human samples. , 1992, Journal of chromatography.

[220]  J G Flanagan,et al.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.

[221]  C. Mattsson,et al.  Inhibition of angiogenesis by heparin fragments in the presence of hydrocortisone , 1992 .

[222]  D. Lane,et al.  Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.

[223]  C. Moffat,et al.  Heparinase II from Flavobacterium heparinum. HPLC analysis of the saccharides generated from chemically modified heparins. , 1991, European journal of biochemistry.

[224]  R. Linhardt,et al.  Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis. , 1991, Analytical biochemistry.

[225]  J. Esko.  Genetic analysis of proteoglycan structure, function and metabolism. , 1991, Current opinion in cell biology.

[226]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[227]  H. Uchiyama,et al.  Changes in the structure and biological property of N----O sulfate-transferred, N-resulfated heparin. , 1991, The Journal of biological chemistry.

[228]  H. Halvorson,et al.  Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. , 1991, The Journal of biological chemistry.

[229]  U. Lindahl,et al.  Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. , 1991, The Biochemical journal.

[230]  R. Rej,et al.  Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin. , 1991, Carbohydrate research.

[231]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[232]  J. Turnbull,et al.  Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure. , 1991, The Biochemical journal.

[233]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[234]  K. Holme,et al.  Marked stereoselectivity in the binding of copper ions by heparin. Contrasts with the binding of gadolinium and calcium ions. , 1990, Carbohydrate research.

[235]  M. Porcionatto,et al.  Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. , 1990, The Journal of biological chemistry.

[236]  A. Edge,et al.  Characterization of novel sequences containing 3-O-sulfated glucosamine in glomerular basement membrane heparan sulfate and localization of sulfated disaccharides to a peripheral domain. , 1990, The Journal of biological chemistry.

[237]  A. Al-Hakim,et al.  Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. , 1990, Journal of medicinal chemistry.

[238]  G. Torri,et al.  Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites. , 1990, The Journal of biological chemistry.

[239]  R. Rej,et al.  Base-catalyzed conversion of the a-l-iduronic acid 2-sulfate unit of heparin into a unit of a-l-galacturonic acid, and related reactions , 1990 .

[240]  B. Perly,et al.  Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. , 1990, Carbohydrate research.

[241]  J. Kovensky,et al.  A suitable method for a rapid estimation of sulphated positions in polysaccharides of pharmacological interest , 1990 .

[242]  A. Al-Hakim,et al.  Isolation and recovery of acidic oligosaccharides from polyacrylamide gels by semi‐dry electrotransfer , 1990, Electrophoresis.

[243]  G. Schettler,et al.  New Trends in Haemostasis , 1990, Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften.

[244]  F. Sauriol,et al.  Novel regio- and stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopic evidence , 1989 .

[245]  M. Petitou,et al.  Heparin‐derived oligosaccharides: Affinity for acidic fibroblast growth factor and effect on its growth‐promoting activity for human endothelial cells , 1989, Journal of cellular physiology.

[246]  L. Kjellén,et al.  Biosynthesis of heparin. Relationship between the polymerization and sulphation processes. , 1989, The Biochemical journal.

[247]  R. Linhardt,et al.  Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases. , 1989, Carbohydrate research.

[248]  R. Linhardt,et al.  Sequence analysis of highly sulfated, heparin-derived oligosaccharides using fast atom bombardment mass spectrometry. , 1989, Analytical chemistry.

[249]  M. Karnovsky,et al.  Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge. , 1989, The Journal of biological chemistry.

[250]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[251]  H. Conrad,et al.  The disaccharide composition of heparins and heparan sulfates. , 1989, Analytical Biochemistry.

[252]  J. Schlessinger,et al.  Signal transduction by allosteric receptor oligomerization. , 1988, Trends in biochemical sciences.

[253]  J. Thomas-Oates,et al.  Fast-atom-bombardment mass-spectrometric strategies for sequencing sulphated oligosaccharides , 1988 .

[254]  M. Petitou,et al.  Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. , 1988, Trends in biochemical sciences.

[255]  A. Lundblad,et al.  Monoclonal antibodies specific for oligosaccharides prepared by partial nitrous acid deamination of heparin. , 1988, The Journal of biological chemistry.

[256]  M. Vert,et al.  Ca2+-heparin interactions: effects of counterions on n.m.r. and c.d. of fractionated heparin and related compounds , 1988 .

[257]  A. Perlin,et al.  A relationship between 13C-chemical-shift displacements and counterion-condensation theory, in the binding of calcium ion by heparin. , 1987, Carbohydrate research.

[258]  J. Esko,et al.  Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. , 1987, The Journal of biological chemistry.

[259]  Å. Danielsson,et al.  Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. , 1987, The Journal of biological chemistry.

[260]  J. Maffrand,et al.  "Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties. , 1987, Biochemical pharmacology.

[261]  R. Linhardt,et al.  Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis. , 1987, The Biochemical journal.

[262]  P. Sanderson,et al.  Conformational equilibria of alpha-L-iduronate residues in disaccharides derived from heparin. , 1987, The Biochemical journal.

[263]  T. Peters,et al.  Conformational analysis of synthetic heparin-like oligosaccharides containing α-L-idopyranosyluronic acid† , 1987 .

[264]  R. Linhardt,et al.  Structure and activity of a unique heparin-derived hexasaccharide. , 1986, The Journal of biological chemistry.

[265]  Benito Casu,et al.  Evidence for conformational equilibrium of the sulfated L-iduronate residue in heparin and in synthetic heparin mono- and oligo-saccharides: NMR and force-field studies , 1986 .

[266]  Massimo Ragazzi,et al.  A force‐field study of the conformational characteristics of the iduronate ring , 1986, Journal of computational chemistry.

[267]  A. Perlin,et al.  N.m.r. spectroscopic observations related to the function of sulfate groups in heparin. Calcium binding vs. biological activity. , 1986, Carbohydrate research.

[268]  K. Antonakis,et al.  Synthesis of 7-[3-bromo-3,4-dideoxy-6-O-(2-hydroxyethyl)-β-d-glycero-hex-3-enopyranosyl-2-ulose]theophylline , 1985 .

[269]  R. Linhardt,et al.  High-performance liquid chromatographic separation of heparin-derived oligosaccharides. , 1985, Analytical biochemistry.

[270]  L. Cöster,et al.  Domain structure of proteoheparan sulphate from confluent cultures of human embryonic skin fibroblasts. , 1985, The Biochemical journal.

[271]  J. Gallagher,et al.  Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides. , 1985, The Biochemical journal.

[272]  Christian Braud,et al.  Structure polyélectrolytique et activité anticoagulante de fractions d'héparine obtenues par chromatographie d'échange d'ions , 1985 .

[273]  R. Linhardt,et al.  Structure of heparin-derived tetrasaccharides. , 1985, The Biochemical journal.

[274]  M. Bienkowski,et al.  Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid. , 1985, The Journal of biological chemistry.

[275]  B. Casu,et al.  Structure and biological activity of heparin. , 1985, Advances in carbohydrate chemistry and biochemistry.

[276]  W. Long,et al.  Flavobacterium heparinum 2-O-sulphatase for 2-O-sulphato-delta 4,5-glycuronate-terminated oligosaccharides from heparin. , 1984, European journal of biochemistry.

[277]  D. Atha,et al.  Sequence variation in heparin octasaccharides with high affinity for antithrombin III. , 1984, Biochemistry.

[278]  P. Sanderson,et al.  Very-high-field n.m.r. studies of bovine lung heparan sulphate tetrasaccharides produced by nitrous acid deaminative cleavage. Determination of saccharide sequence, uronate composition and degrees of sulphation. , 1984, The Biochemical journal.

[279]  A. Linker,et al.  Structural studies on heparin. Tetrasaccharides obtained by heparinase degradation. , 1984, Carbohydrate research.

[280]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[281]  T. Irimura,et al.  Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. , 1983, Science.

[282]  D. Beeler,et al.  Purification and properties of human platelet heparitinase. , 1982, The Journal of biological chemistry.

[283]  M. Kikuchi,et al.  Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies. , 1982, The Biochemical journal.

[284]  U Lindahl,et al.  Further characterization of the antithrombin-binding sequence in heparin. , 1982, Carbohydrate research.

[285]  H. Nader,et al.  A method for rapid quantitation and preparation of antithrombin III--high-affinity heparin fractions. , 1981, Analytical biochemistry.

[286]  Z. Yosizawa,et al.  Sulfated oligosaccharides isolated from the deamination products of heparins. , 1981, Journal of biochemistry.

[287]  A. Malmström,et al.  Periodate oxidation and alkaline degradation of heparin-related glycans , 1980 .

[288]  L. Fransson.  Periodate oxidation of the d-glucuronic acid residues in heparan sulphate and heparin , 1978 .

[289]  C. Dietrich,et al.  Structure of heparin. Characterization of the products formed from heparin by the action of a heparinase and a heparitinase from Flavobacterium heparinum. , 1975, The Journal of biological chemistry.

[290]  M. Höök,et al.  Biosynthesis of heparin. Studies on the microsomal sulfation process. , 1975, The Journal of biological chemistry.

[291]  A. Linker,et al.  The disaccharide repeating-units of heparan sulfate. , 1974, Carbohydrate research.